LAS VEGAS, Jan. 24, 2026 /PRNewswire/ -- Denvix, the official global partner of the Golden State Warriors and a leader in consumer electronics, announced a series of major product launches and brand milestones at CES 2026. During the show, 6x NBA All-Star Jimmy Butler, Global Brand Ambassador of Denvix, made a special appearance at the brand's booth to host an exclusive signing session. Denvix also released its new product, the 3-in-1 Spark (outdoor generator, tire inflator, and jump starter), with cutting-edge innovations and exceptional product performance. This release quickly earned enthusiastic praise from global consumers and high acclaim from industry experts.
As Denvix's Global Brand Ambassador, Jimmy Butler appeared at CES 2026 to host an exclusive signing session. This marks the launch of the limited-edition Jimmy Butler co-branded PowerX. During the appearance, Jimmy shared his perspective on the partnership with Denvix and spoke about his appreciation for the brand's focus on performance and reliability. He also noted his personal connection to the PowerX, mentioning that its use has become part of his daily routine. The signing session drew a lively crowd and generated strong on-site excitement as Jimmy engaged with fans on-site, taking the time to take pictures and sign his co-branded products. His involvement created memorable moments that highlighted the strong connection between the athlete and the Denvix brand.
Alongside Jimmy Butler's appearance, Denvix made the global debut of the new product 3-in-1 Spark, a next-generation portable energy solution that integrates an outdoor generator, tire inflator, and jump starter into one compact device. Spark delivers reliable performance across a wide range of real-world scenarios. From road trips to outdoor adventures and emergency situations, Spark is there when you need it. Following the launch of Spark, Denvix has made it possible for people to carry just one essential device when heading out and has successfully transformed a powerful tool into a truly necessary piece of consumer tech.
Denvix's booth also drew numerous influential content creators, who experienced and shared the products with millions of followers, significantly boosting brand visibility. Distributors from the U.S., Canada, Europe, Japan, and the Middle East also expressed strong interest in long-term partnerships, providing new momentum for Denvix's global market growth. Additionally, Denvix has attracted strong interest from industry professionals and business partners, creating numerous opportunities for commercial collaboration.
The successful showcase at CES 2026 represents a key milestone for Denvix, further solidifying its influence in the consumer electronics sector and accelerating its global expansion. Guided by the philosophy "Technology Leads Life, Innovation Defines Mobility," Denvix continues to deliver groundbreaking products and exceptional experiences to consumers worldwide.
About Denvix
Denvix is a pioneering consumer electronics brand, redefining the way people interact with technology through innovative and high-performance products. By integrating cross-industry demands with cutting-edge technology, Denvix delivers solutions that meet the needs of modern consumers and sets new industry standards.
In 2025, Denvix signed Jimmy Butler III as the global brand ambassador and became the official global partner of the Golden State Warriors. Denvix also expanded its presence in motorsports as a sponsor of NASCAR, further demonstrating its commitment to innovation and performance.
Denvix at CES 2026 jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2868003/CES_____1min_Acopy.mp4', image: 'https://mma.prnasia.com/media2/2868003/CES_____1min_Acopy.mp4?p=medium', autostart:'false', stretching : 'uniform', width: '512', height: '288'});
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Denvix Shines at CES 2026 with Jimmy Butler Appearance and New Product Launch
|
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence.
TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.
In 2026, Avène will conduct a comparative clinical study to evaluate the efficacy of its new treatment for acne-prone skin, Avène Cleanance Comedomed+, in the maintenance phase following oral isotretinoin treatment in adults suffering from severe to very severe acne.
Avène is renowned for its dermatological expertise, inspired by therapeutic know-how, and has been committed to improving the treatment of skin pathologies since 1990. It is thus becoming the first brand to use Artificial Intelligence in clinical studies for dermo-cosmetics.
A concrete illustration of Pierre Fabre Laboratories' "Supportive Care" strategy.
This study is unique in two ways: due to its scientific ambition and because it fully aligns with the "supportive care" strategy of Pierre Fabre Laboratories, launched in 2025.
"We belong to a group that has always been rooted in pharmaceuticals and dermo-cosmetics. Our medical expertise gives us a head start in understanding patients and their pathologies. We are ideally positioned to offer treatment protocols based on the pathology, combining dermo-cosmetics with medication. We are already preparing solutions to go further, by developing dermo-cosmetic innovations capable of extending and amplifying the action of the medication or delaying its necessity. Because these are dermo-cosmetics, they can be used over the long term, unlike many drug treatments," explains Dr. Gautier Doat, Eau Thermale Avène Medical Director.
To continue reading, https://www.pierre-fabre.com/en/news/avene-artificial-intelligence-clinical-studies-dermo-cosmetics
For more information, visit www.pierre-fabre.com, @Laboratoires Pierre Fabre, @Pierre Fabre Oncology
About Eau Thermale Avène: https://www.eau-thermale-avene.fr/
Press contact: Caroline Perdrix Thomas
caroline.perdrix@pierre-fabre.com
*Source: GERS – SOG Early – Pharmacy Channel – Dermo-cosmetics market definition established by Pierre Fabre laboratories – Origin: Sell Out – Cumulative data up to December 2025 in volume (units) and value (revenue inc. taxes).
From 100 to 600 patients: to support patients suffering from acne, Avène, Pierre Fabre Laboratories' leading brand, is strengthening the robustness of its clinical studies via data augmentation through Artificial Intelligence.
TOULOUSE, France, March 11, 2026 /PRNewswire/ -- Avène, the leading brand in French pharmacies*, in partnership with Toulouse-based HealthTech company BotDesign, has announced a major breakthrough in the field of clinical studies in dermo-cosmetics.
In 2026, Avène will conduct a comparative clinical study to evaluate the efficacy of its new treatment for acne-prone skin, Avène Cleanance Comedomed+, in the maintenance phase following oral isotretinoin treatment in adults suffering from severe to very severe acne.
Avène is renowned for its dermatological expertise, inspired by therapeutic know-how, and has been committed to improving the treatment of skin pathologies since 1990. It is thus becoming the first brand to use Artificial Intelligence in clinical studies for dermo-cosmetics.
A concrete illustration of Pierre Fabre Laboratories' "Supportive Care" strategy.
This study is unique in two ways: due to its scientific ambition and because it fully aligns with the "supportive care" strategy of Pierre Fabre Laboratories, launched in 2025.
"We belong to a group that has always been rooted in pharmaceuticals and dermo-cosmetics. Our medical expertise gives us a head start in understanding patients and their pathologies. We are ideally positioned to offer treatment protocols based on the pathology, combining dermo-cosmetics with medication. We are already preparing solutions to go further, by developing dermo-cosmetic innovations capable of extending and amplifying the action of the medication or delaying its necessity. Because these are dermo-cosmetics, they can be used over the long term, unlike many drug treatments," explains Dr. Gautier Doat, Eau Thermale Avène Medical Director.
To continue reading, https://www.pierre-fabre.com/en/news/avene-artificial-intelligence-clinical-studies-dermo-cosmetics
For more information, visit www.pierre-fabre.com, @Laboratoires Pierre Fabre, @Pierre Fabre Oncology
About Eau Thermale Avène: https://www.eau-thermale-avene.fr/
Press contact: Caroline Perdrix Thomas
caroline.perdrix@pierre-fabre.com
*Source: GERS – SOG Early – Pharmacy Channel – Dermo-cosmetics market definition established by Pierre Fabre laboratories – Origin: Sell Out – Cumulative data up to December 2025 in volume (units) and value (revenue inc. taxes).
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics
